ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.737,36
-0,64%
S&P 500
4.967,23
-0,88%
Dow Jones
37.986,40
0,56%
Euro vs US Dollar
1,06705
0,25%
Bitcoin
63.745,91
-0,12%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. BioMarin Pharmaceutical Inc (BMRN)

  7. BioMarin Pharmaceutical Inc (BMRN) News

BMRN BioMarin Pharmaceutical Inc

88,63
-1,44 (-1,60%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:15:01
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
BioMarin Pharmaceutical Inc BMRN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-1,44 -1,60% 88,63 22:15:01
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
89,67 88,29 90,18 88,63 90,07
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
10.4.202414:00PRNUSBioMarin to Host First Quarter 2024 Financial Results..
12.3.202413:30PRNUSNew Data to be Presented for BioMarin's VOXZOGO®..
08.3.202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202414:30PRNUSBioMarin Announces Appointment of Cristin Hubbard as Chief..
06.3.202418:04EDGAR2Form 144 - Report of proposed sale of securities
05.3.202422:17EDGAR2Form 144 - Report of proposed sale of securities
05.3.202420:41EDGAR2Form 144 - Report of proposed sale of securities
05.3.202418:04EDGAR2Form 144 - Report of proposed sale of securities
01.3.202415:00PRNUSBioMarin Scheduled to Participate in March Investor..
29.2.202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202416:35EDGAR2Form 144 - Report of proposed sale of securities
26.2.202419:34EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22.2.202422:06EDGAR2Form 8-K - Current report
22.2.202422:03PRNUSBioMarin Reports Record Financial Results for the Fourth..
12.2.202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202421:24EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
12.2.202421:04EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
09.2.202423:46EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09.2.202416:36EDGAR2Form 144 - Report of proposed sale of securities
08.2.202415:46EDGAR2Form 144 - Report of proposed sale of securities
08.2.202414:00PRNUSBioMarin to Host Fourth Quarter and Full-Year 2023 Financial..
06.2.202414:30PRNUSBioMarin to Present ROCTAVIAN™ (valoctocogene..
26.1.202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24.1.202401:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.1.202422:06EDGAR2Form 8-K - Current report
11.1.202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202416:09EDGAR2Form 144 - Report of proposed sale of securities
09.1.202417:48EDGAR2Form 144 - Report of proposed sale of securities
03.1.202414:00PRNUSBioMarin to Present at the 42nd Annual J.P. Morgan..
28.12.202319:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.12.202319:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
28.12.202319:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.12.202319:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
28.12.202319:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.12.202319:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
22.12.202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202315:57EDGAR2Form 144 - Report of proposed sale of securities
20.12.202323:22EDGAR2Form 8-K - Current report
20.12.202322:05PRNUSBioMarin Announces Governance Enhancements and Value..
15.12.202300:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202317:49EDGAR2Form 144 - Report of proposed sale of securities
13.12.202301:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202323:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
BMRN
BioMarin Pharmaceutical
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten